All ORF cDNA clones (the Product) are subject to the following policy. In this Policy, Customers of GeneCopoeia products are referred to as Buyers and distributors who sell GeneCopoeia products are referred to as Resellers.
GeneCopoeia quality assurance policy ensures that all OmicsLink™ ORF cDNA Expression Clones are free of artificial frame-shifting variations including deletions(s) and additions(s) of base(s) and translation termination mutation(s) (non-stop codon to stop codon as the result of point mutation). This policy does not cover point variations due to possible naturally occurring polymorphisms and/or mutations that may be introduced by PCR in very rare cases. If Buyer requests a specific version of a gene from different cDNA libraries, GeneCopoeia will make its best effort to obtain that particular version but without guarantee of success. For this recloning effort, Buyer is to pay a fee that will be fairly negotiated between Reseller and GeneCopoeia. Splicing variants are replaceable subject to availabilities and a modest fee to cover the cloning cost. In the event that requested ORF clone(s) of specific splicing variant(s) are not available, GeneCopoeia will make its best effort to clone it and Buyer will pay a fee that will be fairly negotiated between Reseller and GeneCopoeia.
A limited use license is granted to the Buyer of the Product. The Product shall be used by the Buyer for internal research purposes only and should not be transferred (in any way) to any third party. The Product is expressly not designed, intended, or warranted for clinical use in humans or for therapeutic or diagnostic use. The Product must not be resold, repackaged or modified for resale (includes but is not limited to the transferring of full-length ORF(s) from GeneCopoeia ORF clones to other expression vectors), or used to manufacture commercial products without prior written consent from GeneCopoeia. This Product should be used in accordance with the NIH guidelines developed for recombinant DNA and genetic research. Use of any part of the Product constitutes acceptance of the above terms.